Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

iwCLL 2019 | National genomic projects in the UK for CLL diagnostics

Anna Schuh • 22 Sep 2019
iwCLL 2019
Chronic Lymphocytic Leukemia Leukemia

Anna Schuh, MD, PhD, Oxford University Hospitals, Oxford, UK, talks about UK genomic projects including the 100,000 Human Genomes Project that can help personalize diagnosis of chronic lymphocytic leukemia (CLL). This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

More from Anna Schuh

Ongoing projects to improve the outcomes of patients with CLL in resource-limited settings 5:51
Ongoing projects to improve the outcomes of patients with CLL in resource-limited settings
Anna Schuh • 14 Sep 2025
The key challenges in accessing and delivering CLL treatment in resource-limited settings 1:49
The key challenges in accessing and delivering CLL treatment in resource-limited settings
Anna Schuh • 14 Sep 2025
The paradigm shift needed in CLL research and clinical trials 2:49
The paradigm shift needed in CLL research and clinical trials
Anna Schuh • 14 Sep 2025
Updates to the ESMO CLL clinical practice guidelines: implications for frontline treatment 36:40
Updates to the ESMO CLL clinical practice guidelines: implications for frontline treatment
Anna Schuh et al. • 20 Mar 2025

Related Videos

The value and mission of the International Workshop on Acute Leukemias 14:36
The value and mission of the International Workshop on Acute Leukemias
Charles Craddock et al. • 21 Oct 2025
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years? 1:30
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years?
Koichi Takahashi • 26 Sep 2025
One big question with Naval Daver: what AML advance could transform frontline care in three years? 1:05
One big question with Naval Daver: what AML advance could transform frontline care in three years?
Naval Daver • 26 Sep 2025
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years? 3:13
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years?
Charles Craddock • 26 Sep 2025
The content of VJHemOnc is intended for healthcare professionals